Next Article in Journal
Eating Disorders, Physical Fitness and Sport Performance: A Systematic Review
Next Article in Special Issue
Vitamin D and Human Health: Celebrating Diversity
Previous Article in Journal
Diurnal Triglyceridemia in Relation to Alcohol Intake in Men
Previous Article in Special Issue
The Importance of Dose, Frequency and Duration of Vitamin D Supplementation for Plasma 25-Hydroxyvitamin D
Nutrients 2013, 5(12), 5127-5139; doi:10.3390/nu5125127

Does Vitamin D Sufficiency Equate to a Single Serum 25-Hydroxyvitamin D Level or Are Different Levels Required for Non-Skeletal Diseases?

1,* , 2
1 Division of Health Sciences, University of South Australia, Adelaide, SA 5000, Australia 2 Discipline of General Practice, School of Population Health, University of Adelaide, Adelaide, SA 5005, Australia 3 SA Pathology, PO Box 14, Rundle Mall, Adelaide, SA 5000, Australia 4 School of Population Health, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
* Author to whom correspondence should be addressed.
Received: 28 October 2013 / Revised: 27 November 2013 / Accepted: 28 November 2013 / Published: 16 December 2013
(This article belongs to the Special Issue Vitamin D and Human Health)
View Full-Text   |   Download PDF [214 KB, 19 December 2013; original version 16 December 2013]


Objective: Clarify the concept of vitamin D sufficiency, the relationship between efficacy and vitamin D status and the role of Vitamin D supplementation in the management of non-skeletal diseases. We outline reasons for anticipating different serum vitamin D levels are required for different diseases. Method: Review the literature for evidence of efficacy of supplementation and minimum effective 25-hydroxyvitamin D (25-OHD) levels in non-skeletal disease. Results: Evidence of efficacy of vitamin supplementation is graded according to levels of evidence. Minimum effective serum 25-OHD levels are lower for skeletal disease, e.g., rickets (25 nmol/L), osteoporosis and fractures (50 nmol/L), than for premature mortality (75 nmol/L) or non-skeletal diseases, e.g., depression (75 nmol/L), diabetes and cardiovascular disease (80 nmol/L), falls and respiratory infections (95 nmol/L) and cancer (100 nmol/L). Conclusions: Evidence for the efficacy of vitamin D supplementation at serum 25-OHD levels ranging from 25 to 100 nmol/L has been obtained from trials with vitamin D interventions that change vitamin D status by increasing serum 25-OHD to a level consistent with sufficiency for that disease. This evidence supports the hypothesis that just as vitamin D metabolism is tissue dependent, so the serum levels of 25-OHD signifying deficiency or sufficiency are disease dependent.
Keywords: vitamin D; dose response; thresholds; prevention; chronic disease vitamin D; dose response; thresholds; prevention; chronic disease
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Spedding, S.; Vanlint, S.; Morris, H.; Scragg, R. Does Vitamin D Sufficiency Equate to a Single Serum 25-Hydroxyvitamin D Level or Are Different Levels Required for Non-Skeletal Diseases? Nutrients 2013, 5, 5127-5139.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert